[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 184.73.122.162. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
September 14, 1994

Strategies for Cadaveric Organ ProcurementMandated Choice and Presumed Consent

Author Affiliations

Durham, NC; Anaheim, Calif; Dallas, Tex; Gallipolis, Ohio; Columbus, Ohio; Boston, Mass; Los Angeles, Calif; Edwardsville, III; Buffalo, NY; Chicago, III; Karey Harwood, Chicago, III; Chicago, III.
From the Council on Ethical and Judicial Affairs, American Medical Association, Chicago, III.

JAMA. 1994;272(10):809-812. doi:10.1001/jama.1994.03520100071036
Abstract

THE SCARCITY OF ORGANS FOR TRANSPLANTATION  The shortage of organs for transplantation is becoming more critical every year. Because of improvements in transplantation procedures, beginning with the advent of immunosuppressive therapies in the early 1980s, more patients now benefit from organ transplantation. As a result of transplantation's success, waiting lists for donor organs are increasingly crowded. Between December 1987 and June 1991, for example, the total number of patients on organ transplant waiting lists increased 75.3%, from 13153 to 23 056 patients.1For editorial comment see p 814.Tragically, the supply of donated organs has not kept up with this demand. Between 1987 and 1990, the number of organ donors per year stayed nearly constant, increasing from 4000 to 4357.1 Even though each cadaveric organ donor can often supply multiple organs for transplantation, many patients still die before a suitable organ becomes available. In September 1991, the United

First Page Preview View Large
First page PDF preview
First page PDF preview
×